Price target
476.750.000.00%
The 28 analysts offering 1 year price forecasts for 4VRTX have a max estimate of — and a min estimate of —.
Analyst rating
Based on 37 analysts giving stock ratings to 4VRTX in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
4VRTX EPS for the last quarter is 3.93 EUR despite the estimation of 3.66 EUR. In the next quarter EPS is expected to reach 3.76 EUR. Track more of VERTEX PHARMACEUTICALS financials and stay on top of what is up with the company.
In the next quarter VERTEX PHARMACEUTICALS revenue is expected to reach 2.58 B EUR. Check out VERTEX PHARMACEUTICALS revenue and earnings and make informed decisions.
According to analysts, 4VRTX price target is 476.75 EUR with a max estimate of 550.84 EUR and a min estimate of 297.38 EUR. Check if this forecast comes true in a year, meanwhile watch VERTEX PHARMACEUTICALS stock price chart and keep track of the current situation with 4VRTX news and stock market news.
We've gathered opinions of 37 analysts rating 4VRTX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.